Skip to main content

Displaying 1 - 20 of 103

Apitor

The FTC reached a settlement with Apitor Technology over allegations that its app enabled a third party in China to collect geolocation information from children without parental consent.

Type of Action
Federal
Last Updated
Case Status
Pending

Precision Patient Outcomes

In November 2022, the FTC filed a complaint in court seeing civil penalties against California-based Precision Patient Outcomes, Inc. and the company’s CEO Margrett Priest Lewis for marketing an over-the-counter dietary supplement containing nothing more than vitamins, zinc, and a flavonoid as an effective treatment to mitigate the effects of COVID-19. In February 2024, the FTC announced an order settling its allegations that bars the defendants from the alleged deceptive practices.

Type of Action
Federal
Last Updated
FTC Matter/File Number
2123137
Case Status
Pending